PAR3 is a cofactor for PAR4 activation by thrombin

Nature

Volumn 404, Issue 6778, 2000, Pages 609-613

  Hakanishi Matsui, Mayumi ^a   Zheng, Yao Wu ^a   Sulciner, David J ^a,b   Welss, Ethan J ^a,b   Ludeman, Matthew J ^a   Coughlin, Shaun R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 3; THROMBIN; THROMBIN RECEPTOR;

ANIMAL CELL; ARTICLE; CERCOPITHECIDAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PLATELETS; COS CELLS; GTP-BINDING PROTEINS; HIRUDINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PLATELET ACTIVATION; PROTEIN BINDING; RECEPTORS, THROMBIN; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; THROMBIN;

ANIMALIA; CERCOPITHECIDAE; RICKETTSIA SP. PAR;

EID: 0034611727     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35007085     Document Type: Article

References (25)

1. Coughlin, S. R. How the protease thrombin talks to cells. Proc. Natl Acad. Sci. USA 96, 11023-11027 (1999).
2. Ishihara, H. et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386, 502-506 (1997).
3. Kahn, M. L. et al. A dual thrombin receptor system for platelet activation. Nature 394, 690-694 (1998).
4. Ishihara, H., Zeng, D., Connolly, A. J., Tam, C. & Coughlin, S. R. Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin. Blood 91, 4152-4157 (1998).
5. Kuner, R. et al. Role of heteromer formation in GABAB receptor function. Science 283, 74-77 (1999).
6. Jordan, B. A. & Devi, L. A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697-699 (1999).
7. B receptor. Nature 396, 679-682 (1998).
8. B-receptor subtypes assemble into functional heteromeric complexes. Nature 396, 683-687 (1998).
9. Kahn, M.L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H. & Coughlin, S. R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103, 879-887 (1999).
10. Vu, T. -K. H., Wheaton, V. I., Hung, D. T. & Coughlin, S. R. Domains specifying thrombin-receptor interaction. Nature 353, 674-677 (1991).
11. Liu, L., Vu, T. -K. H., Esmon, C. T. & Coughlin, S. R. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J. Biol. Chem. 266, 16977-16980 (1991).
12. Mathews, I. I. et al. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry 33, 3266-3279 (1994).
13. Ishii, K., Gerszten, R., Zheng, Y. -W., Turck, C. W. & Coughlin, S. R. Determinants of thrombin receptor cleavage: receptor domains involved, specificity, and role of the P3 aspartate. J. Biol. Chem. 270, 16435-16440 (1995).
14. Ishii, K., Hein, L., Kobilka, B. & Coughlin, S. R. Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J. Biol. Chem. 268, 9780-9786 (1993).
15. Vu, T. -K. H., Hung, D. T., Wheaton, V. I. & Coughlin, S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068 (1991).
16. Xu, W. F. et al. Cloning and characterization of human protease-activated receptor 4. Proc. Natl Acad. Sci. USA 95, 6642-6646 (1998).
17. Okamura, T., Hasitz, M. & Jamieson, G. A. Platelet glycocalicin: interaction with thrombin and role as thrombin receptor on the platelet surface. J. Biol. Chem. 253, 3435-3443 (1978).
18. Colman, R. W., Marder, V. J., Salzman, E. W. & Hirsh, J. in Hemostasis and Thrombosis (eds Colman, R. W., Marder, V. J., Salzman, E. W. & Hirsh, J.) 3-18 (Lippincott, Philadelphia, 1994).
19. Ulevitch, R. J. & Tobias, P. S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13, 437-457 (1995).
20. Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J. & Gusovsky, F. Toll like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689-10692 (1999).
21. Heinrich, P. C., Behrmann, I., Müller-Newen, G., Schaper, F. & Graeve, L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334, 297-314 (1998).
22. Klagsbrun, M. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin. Cancer Biol. 3, 81-87 (1992).
23. Vivien, D., Attisano, L., Wrana, J. L. & Massagué, J. Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes. J. Biol. Chem. 270, 7134-7141 (1995).
24. Chen, J., Ishii, M., Wang, L., Ishii, K. & Coughlin, S. R. Thrombin receptor activation: confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J. Biol. Chem. 269, 16041-16045 (1994).
25. Sage, S. O. in Platelets, A Practical Approach (eds Watson, S. P. & Authi, K. S.) 67-90 (IRL, Oxford, 1996).